Delivering bioanalytical solutions throughout drug development for small and large molecules.
Our bioanalytical services department boasts a 2% batch failure rate versus the industry standard of 5% proving that our process is both efficient and effective. We have a team of globally recognised experts with significant experience in supporting all stages of drug development, from early preclinical through to Phase II and Phase III studies. Our approach is highly responsive which means lead times are typically 6 weeks against an industry standard of 12 weeks.
We have a broad range of knowledge, combining the expertise of biotransformation specialists with analytical, biological and synthetic chemists. Collaboration is fostered through our all-in-one, state-of-the-art facility, where the brightest minds work closely together and employ the latest technological innovations to analyse your drug molecule.
Our services are offered both on a stand-alone basis and as part of an integrated service offering.